Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 224 articles:
HTML format
Text format



Single Articles


    August 2019
  1. LI B, He Y, Ma J, Huang P, et al
    Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Alzheimers Dement. 2019 Aug 13. pii: S1552-5260(19)35123.
    PubMed     Text format     Abstract available


  2. OTTOY J, Verhaeghe J, Niemantsverdriet E, De Roeck E, et al
    (18)F-FDG PET, the early phases and the delivery rate of (18)F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against (15)O-H2O PET.
    Alzheimers Dement. 2019 Aug 9. pii: S1552-5260(19)30151.
    PubMed     Text format     Abstract available


  3. JELLINGER KA
    Traumatic brain injury and Alzheimer's disease neuropathology.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)34082.
    PubMed     Text format    


  4. GREEN C, Handels R, Gustavsson A, Wimo A, et al
    Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)30139.
    PubMed     Text format     Abstract available


  5. OH J, Eser RA, Ehrenberg AJ, Morales D, et al
    Profound degeneration of wake-promoting neurons in Alzheimer's disease.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)34081.
    PubMed     Text format     Abstract available


  6. SAKAE N, Josephs KA, Litvan I, Murray ME, et al
    Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome.
    Alzheimers Dement. 2019 Aug 6. pii: S1552-5260(19)30115.
    PubMed     Text format     Abstract available


  7. YU JT, Li JQ, Suckling J, Feng L, et al
    Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study.
    Alzheimers Dement. 2019 Aug 6. pii: S1552-5260(19)30147.
    PubMed     Text format     Abstract available


  8. BOS I, Vos SJB, Schindler SE, Hassenstab J, et al
    Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.
    Alzheimers Dement. 2019 Aug 1. pii: S1552-5260(19)30122.
    PubMed     Text format     Abstract available


  9. MAHLA RS
    Down syndrome cognitive marker's significance in Alzheimer's disease and dementia management.
    Alzheimers Dement. 2019;15:1117-1118.
    PubMed     Text format    


    July 2019
  10. FILSHTEIN TJ, Brenowitz WD, Mayeda ER, Hohman TJ, et al
    Reserve and Alzheimer's disease genetic risk: Effects on hospitalization and mortality.
    Alzheimers Dement. 2019;15:907-916.
    PubMed     Text format     Abstract available


    June 2019
  11. LUTZ MW, Sprague D, Chiba-Falek O
    Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causation.
    Alzheimers Dement. 2019 Jun 28. pii: S1552-5260(19)30121.
    PubMed     Text format     Abstract available


  12. LI H, Habes M, Wolk DA, Fan Y, et al
    A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.
    Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30086.
    PubMed     Text format     Abstract available


  13. STRANDBERG TE, Tienari PJ
    Contributions of vascular and Alzheimer's disease pathology to dementia.
    Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30108.
    PubMed     Text format    


  14. MIRON J, Picard C, Lafaille-Magnan ME, Savard M, et al
    Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.
    Alzheimers Dement. 2019 Jun 4. pii: S1552-5260(19)30087.
    PubMed     Text format     Abstract available


  15. VERMUNT L, Sikkes SAM, van den Hout A, Handels R, et al
    Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
    Alzheimers Dement. 2019 Jun 1. pii: S1552-5260(19)30084.
    PubMed     Text format     Abstract available


    May 2019
  16. CHIESA PA, Cavedo E, Vergallo A, Lista S, et al
    Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease.
    Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30077.
    PubMed     Text format     Abstract available


  17. VERGALLO A, Megret L, Lista S, Cavedo E, et al
    Plasma amyloid beta 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
    Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30082.
    PubMed     Text format     Abstract available


  18. RODRIGUEZ-GOMEZ O, Rodrigo A, Iradier F, Santos-Santos MA, et al
    The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
    Alzheimers Dement. 2019 May 6. pii: S1552-5260(19)30072.
    PubMed     Text format     Abstract available



  19. Erratum to "Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice" [Alzheimer's & Dementia 2016;12:1273-87.].
    Alzheimers Dement. 2019 May 4. pii: S1552-5260(19)30117.
    PubMed     Text format    


  20. SCHEEPERS LEJM, Jacobsson LTH, Kern S, Johansson L, et al
    Urate and risk of Alzheimer's disease and vascular dementia: A population-based study.
    Alzheimers Dement. 2019 May 2. pii: S1552-5260(19)30046.
    PubMed     Text format     Abstract available


    April 2019
  21. MORGAN AR, Touchard S, Leckey C, O'Hagan C, et al
    Inflammatory biomarkers in Alzheimer's disease plasma.
    Alzheimers Dement. 2019 Apr 29. pii: S1552-5260(19)30078.
    PubMed     Text format     Abstract available


  22. KIM M, Snowden S, Suvitaival T, Ali A, et al
    Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
    Alzheimers Dement. 2019 Apr 28. pii: S1552-5260(19)30074.
    PubMed     Text format     Abstract available


  23. WOO BKP, Chung S, Woo G, Chung JOP, et al
    Mitigating stigma of Alzheimer's disease dementia among Chinese Americans.
    Alzheimers Dement. 2019 Apr 25. pii: S1552-5260(19)30079.
    PubMed     Text format    


  24. GOEDERT M
    Aaron Klug and the study of Alzheimer's disease.
    Alzheimers Dement. 2019 Apr 19. pii: S1552-5260(19)30054.
    PubMed     Text format    


  25. LLEO A, Alcolea D, Martinez-Lage P, Scheltens P, et al
    Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
    Alzheimers Dement. 2019 Apr 6. pii: S1552-5260(19)30047.
    PubMed     Text format     Abstract available


    March 2019
  26. BIHLMEYER NA, Merrill E, Lambert Y, Srivastava GP, et al
    Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 29. pii: S1552-5260(19)30032.
    PubMed     Text format     Abstract available



  27. Erratum to "Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome" [Alzheimer's & Dementia 2019;15:76-92.].
    Alzheimers Dement. 2019 Mar 21. pii: S1552-5260(19)30055.
    PubMed     Text format    


  28. KOUNTOURAS J, Doulberis M, Polyzos SA, Katsinelos T, et al
    Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.
    Alzheimers Dement. 2019 Mar 11. pii: S1552-5260(19)30029.
    PubMed     Text format    


  29. WHITWELL JL, Martin P, Graff-Radford J, Machulda MM, et al
    The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30010.
    PubMed     Text format     Abstract available


  30. BOS I, Vos S, Verhey F, Scheltens P, et al
    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30018.
    PubMed     Text format     Abstract available


  31. JELLINGER KA
    Primary age-related tauopathy (PART) and Alzheimer's disease (AD).
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30019.
    PubMed     Text format    


  32. SUGARMAN MA, McKee AC, Stein TD, Tripodis Y, et al
    Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.
    Alzheimers Dement. 2019 Mar 6. pii: S1552-5260(19)30009.
    PubMed     Text format     Abstract available


  33. SCHINDLER SE, Li Y, Todd KW, Herries EM, et al
    Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 4. pii: S1552-5260(19)30013.
    PubMed     Text format     Abstract available


    February 2019
  34. GUTIERREZ J, Guzman V, Khasiyev F, Manly J, et al
    Brain arterial dilatation and the risk of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30012.
    PubMed     Text format     Abstract available


  35. JELLINGER KA
    Parkinsonism in MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30002.
    PubMed     Text format    


  36. ZHANG F, Zhong R, Li S, Fu Z, et al
    Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline.
    Alzheimers Dement. 2019 Feb 25. pii: S1552-5260(18)33621.
    PubMed     Text format     Abstract available


  37. WANG G, Coble D, McDade EM, Hassenstab J, et al
    Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Alzheimers Dement. 2019 Feb 14. pii: S1552-5260(18)33625.
    PubMed     Text format     Abstract available


  38. SANTOS OA, Pedraza O, Lucas JA, Duara R, et al
    Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.
    Alzheimers Dement. 2019 Feb 12. pii: S1552-5260(18)33630.
    PubMed     Text format     Abstract available


  39. ROGALSKI EJ, Sridhar J, Martersteck A, Rader B, et al
    Clinical and cortical decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 11. pii: S1552-5260(18)33620.
    PubMed     Text format     Abstract available


  40. LANGBAUM JB, Karlawish J, Roberts JS, Wood EM, et al
    GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Alzheimers Dement. 2019 Feb 6. pii: S1552-5260(18)33624.
    PubMed     Text format     Abstract available



  41. Erratum to "Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults" [Alzheimer's & Dementia 2018;14:1640-50.].
    Alzheimers Dement. 2019;15:319.
    PubMed     Text format    



  42. Erratum to "Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies" [Alzheimer's & Dementia 2018;14:707-22.].
    Alzheimers Dement. 2019;15:319.
    PubMed     Text format    


    January 2019
  43. WOSTYN P, Van Dam D, De Deyn PP
    Alzheimer's disease and glaucoma: Look-alike neurodegenerative diseases.
    Alzheimers Dement. 2019 Jan 31. pii: S1552-5260(18)33629.
    PubMed     Text format    


  44. MATTSSON N, Insel PS, Donohue M, Jogi J, et al
    Predicting diagnosis and cognition with (18)F-AV-1451 tau PET and structural MRI in Alzheimer's disease.
    Alzheimers Dement. 2019 Jan 9. pii: S1552-5260(18)33605.
    PubMed     Text format     Abstract available


  45. THOMAS KR, Eppig JS, Weigand AJ, Edmonds EC, et al
    Artificially low mild cognitive impairment to normal reversion rate in Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Jan 2. pii: S1552-5260(18)33603.
    PubMed     Text format     Abstract available


  46. MCCLEERY J, Flicker L, Richard E, Quinn TJ, et al
    The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.
    Alzheimers Dement. 2019;15:179-181.
    PubMed     Text format    


  47. SWEENEY MD, Montagne A, Sagare AP, Nation DA, et al
    Vascular dysfunction-The disregarded partner of Alzheimer's disease.
    Alzheimers Dement. 2019;15:158-167.
    PubMed     Text format     Abstract available


  48. JAGUST W, Jack CR Jr, Bennett DA, Blennow K, et al
    "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".
    Alzheimers Dement. 2019;15:153-157.
    PubMed     Text format    


  49. LOUIE R
    The 2018 NIA-AA research framework: Recommendation and comments.
    Alzheimers Dement. 2019;15:182-183.
    PubMed     Text format    


  50. ALTIMUS CM, Keller K, Brannelly P, Ross E, et al
    Analysis of tauopathy research funding between 2006 and 2016 reveals critical gaps in research priorities.
    Alzheimers Dement. 2019;15:42-54.
    PubMed     Text format     Abstract available


    December 2018
  51. SLOT RER, Sikkes SAM, Berkhof J, Brodaty H, et al
    Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33563.
    PubMed     Text format     Abstract available


  52. BABULAL GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, et al
    Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33556.
    PubMed     Text format     Abstract available


    November 2018
  53. ZHANG X, Zhu C, Beecham G, Vardarajan BN, et al
    A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 29. pii: S1552-5260(18)33579.
    PubMed     Text format     Abstract available


  54. XIONG F, Ge W, Ma C
    Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 28. pii: S1552-5260(18)33580.
    PubMed     Text format     Abstract available


  55. BELL WR, An Y, Kageyama Y, English C, et al
    Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy and Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33483.
    PubMed     Text format     Abstract available


  56. LATIMER CS, Shively CA, Keene CD, Jorgensen MJ, et al
    A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33246.
    PubMed     Text format     Abstract available


  57. STARTIN CM, Hamburg S, Hithersay R, Al-Janabi T, et al
    Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.
    Alzheimers Dement. 2018 Nov 15. pii: S1552-5260(18)33518.
    PubMed     Text format     Abstract available


  58. CHEN Z, Mengel D, Keshavan A, Rissman RA, et al
    Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 9. pii: S1552-5260(18)33561.
    PubMed     Text format     Abstract available


  59. ISAACSON RS, Ganzer CA, Hristov H, Hackett K, et al
    The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
    Alzheimers Dement. 2018 Nov 5. pii: S1552-5260(18)33513.
    PubMed     Text format     Abstract available


    October 2018
  60. PALMQVIST S, Insel PS, Zetterberg H, Blennow K, et al
    Accurate risk estimation of beta-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
    Alzheimers Dement. 2018 Oct 23. pii: S1552-5260(18)33524.
    PubMed     Text format     Abstract available


  61. JOIE R, Ayakta N, Seeley WW, Borys E, et al
    Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Oct 19. pii: S1552-5260(18)33523.
    PubMed     Text format     Abstract available


  62. NHO K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, et al
    Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
    Alzheimers Dement. 2018 Oct 15. pii: S1552-5260(18)33521.
    PubMed     Text format     Abstract available


  63. HU X, Teunissen C, Spottke A, Heneka MT, et al
    Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33527.
    PubMed     Text format     Abstract available


  64. VEITCH DP, Weiner MW, Aisen PS, Beckett LA, et al
    Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33514.
    PubMed     Text format     Abstract available


  65. HUANG F, Wang M, Liu R, Wang JZ, et al
    CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33522.
    PubMed     Text format     Abstract available


  66. SANDELIUS A, Portelius E, Kallen A, Zetterberg H, et al
    Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33515.
    PubMed     Text format     Abstract available


  67. MOIR RD, Lathe R, Tanzi RE
    The antimicrobial protection hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 9. pii: S1552-5260(18)33228.
    PubMed     Text format     Abstract available


  68. MAHMOUDIANDEHKORDI S, Arnold M, Nho K, Ahmad S, et al
    Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    Alzheimers Dement. 2018 Oct 8. pii: S1552-5260(18)33486.
    PubMed     Text format     Abstract available


  69. SHAW LM, Arias J, Blennow K, Galasko D, et al
    Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 3. pii: S1552-5260(18)33492.
    PubMed     Text format     Abstract available


  70. KODIS EJ, Choi S, Swanson E, Ferreira G, et al
    N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-beta oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Alzheimers Dement. 2018;14:1302-1312.
    PubMed     Text format     Abstract available


    September 2018
  71. MULLER S, Preische O, Sohrabi HR, Graber S, et al
    Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 21. pii: S1552-5260(18)33248.
    PubMed     Text format     Abstract available


  72. RASMUSSEN KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, et al
    An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.
    Alzheimers Dement. 2018 Sep 19. pii: S1552-5260(18)33496.
    PubMed     Text format     Abstract available


  73. LIN YF, Smith AV, Aspelund T, Betensky RA, et al
    Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Alzheimers Dement. 2018 Sep 18. pii: S1552-5260(18)33493.
    PubMed     Text format     Abstract available


  74. MATTHEWS KA, Xu W, Gaglioti AH, Holt JB, et al
    Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >/=65 years.
    Alzheimers Dement. 2018 Sep 17. pii: S1552-5260(18)33252.
    PubMed     Text format     Abstract available


  75. SASAKI S
    High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 14. pii: S1552-5260(18)33243.
    PubMed     Text format     Abstract available


  76. RAJAN KB, Weuve J, Barnes LL, Wilson RS, et al
    Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study.
    Alzheimers Dement. 2018 Sep 6. pii: S1552-5260(18)33484.
    PubMed     Text format     Abstract available


  77. CAVEDO E, Chiesa PA, Houot M, Ferretti MT, et al
    Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
    Alzheimers Dement. 2018;14:1204-1215.
    PubMed     Text format     Abstract available


  78. BEYDOUN MA, Beydoun HA, Elbejjani M, Dore GA, et al
    Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys.
    Alzheimers Dement. 2018;14:1148-1158.
    PubMed     Text format     Abstract available


  79. MIELKE MM, Ferretti MT, Iulita MF, Hayden K, et al
    Sex and gender in Alzheimer's disease - Does it matter?
    Alzheimers Dement. 2018;14:1101-1103.
    PubMed     Text format    


    August 2018
  80. NICOLAS G, Acuna-Hidalgo R, Keogh MJ, Quenez O, et al
    Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 13. pii: S1552-5260(18)33245.
    PubMed     Text format     Abstract available


  81. TANG Y, Lutz MW, Xing Y
    A systems-based model of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 10. pii: S1552-5260(18)33247.
    PubMed     Text format     Abstract available


  82. LEE CS, Larson EB, Gibbons LE, Lee AY, et al
    Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 2. pii: S1552-5260(18)33034.
    PubMed     Text format     Abstract available


    July 2018
  83. VERGALLO A, Bun RS, Toschi N, Baldacci F, et al
    Association of cerebrospinal fluid alpha-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers.
    Alzheimers Dement. 2018 Jul 25. pii: S1552-5260(18)33241.
    PubMed     Text format     Abstract available


    June 2018
  84. RUTHIRAKUHAN M, Lanctot KL, Di Scipio M, Ahmed M, et al
    Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30157.
    PubMed     Text format     Abstract available


  85. HANSSON O, Mikulskis A, Fagan AM, Teunissen C, et al
    The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30162.
    PubMed     Text format     Abstract available


  86. YOO HS, Jeon S, Chung SJ, Evans AC, et al
    Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30164.
    PubMed     Text format     Abstract available


  87. CUMMINGS J
    The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30160.
    PubMed     Text format     Abstract available


    May 2018
  88. NEBEL RA, Aggarwal NT, Barnes LL, Gallagher A, et al
    Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
    Alzheimers Dement. 2018 May 31. pii: S1552-5260(18)30130.
    PubMed     Text format     Abstract available


  89. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
    Alzheimers Dement. 2018 May 26. pii: S1552-5260(18)30155.
    PubMed     Text format    


  90. BUCKLEY RF, Mormino EC, Amariglio RE, Properzi MJ, et al
    Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
    Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132.
    PubMed     Text format     Abstract available


  91. TEIPEL SJ, Cavedo E, Lista S, Habert MO, et al
    Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30126.
    PubMed     Text format     Abstract available


  92. JOHANSSON JU, Brubaker WD, Javitz H, Bergen AW, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30125.
    PubMed     Text format     Abstract available


  93. SAEED U, Mirza SS, MacIntosh BJ, Herrmann N, et al
    APOE-epsilon4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Alzheimers Dement. 2018 May 18. pii: S1552-5260(18)30127.
    PubMed     Text format     Abstract available


  94. IWATSUBO T, Iwata A, Suzuki K, Ihara R, et al
    Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Alzheimers Dement. 2018 May 8. pii: S1552-5260(18)30102.
    PubMed     Text format     Abstract available


  95. BROOKMEYER R, Abdalla N
    Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Alzheimers Dement. 2018 May 7. pii: S1552-5260(18)30098.
    PubMed     Text format     Abstract available


  96. LI P, Yu L, Lim ASP, Buchman AS, et al
    Fractal regulation and incident Alzheimer's disease in elderly individuals.
    Alzheimers Dement. 2018 May 4. pii: S1552-5260(18)30108.
    PubMed     Text format     Abstract available


    April 2018
  97. MIELKE MM, Hagen CE, Xu J, Chai X, et al
    Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
    Alzheimers Dement. 2018 Apr 4. pii: S1552-5260(18)30067.
    PubMed     Text format     Abstract available


  98. SILVERBERG N, Elliott C, Ryan L, Masliah E, et al
    NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:576-578.
    PubMed     Text format    


  99. KNOPMAN DS, Haeberlein SB, Carrillo MC, Hendrix JA, et al
    The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Alzheimers Dement. 2018;14:563-575.
    PubMed     Text format     Abstract available


  100. JACK CR JR., Bennett DA, Blennow K, Carrillo MC, et al
    NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:535-562.
    PubMed     Text format     Abstract available


  101. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Alzheimers Dement. 2018;14:532-534.
    PubMed     Text format    


    March 2018
  102. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30074.
    PubMed     Text format     Abstract available


  103. DARWEESH SKL, Wolters FJ, Ikram MA, de Wolf F, et al
    Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30068.
    PubMed     Text format     Abstract available


  104. VERMUNT L, Veal CD, Meulen LT, Chrysostomou C, et al
    European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30064.
    PubMed     Text format     Abstract available


  105. SHI M, Tang L, Toledo JB, Ginghina C, et al
    Cerebrospinal fluid alpha-synuclein contributes to the differential diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30069.
    PubMed     Text format     Abstract available


  106. CACCIAGLIA R, Molinuevo JL, Falcon C, Brugulat-Serrat A, et al
    Effects of APOE-epsilon4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30044.
    PubMed     Text format     Abstract available


  107. MATTSSON N, Groot C, Jansen WJ, Landau S, et al
    Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30063.
    PubMed     Text format     Abstract available


  108. SUTPHEN CL, McCue L, Herries EM, Xiong C, et al
    Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30031.
    PubMed     Text format     Abstract available


  109. GOLDMAN DP, Fillit H, Neumann P
    Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30050.
    PubMed     Text format     Abstract available


  110. STITES SD, Rubright JD, Karlawish J
    What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.
    Alzheimers Dement. 2018 Mar 17. pii: S1552-5260(18)30025.
    PubMed     Text format     Abstract available


  111. SMITH RG, Hannon E, De Jager PL, Chibnik L, et al
    Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Mar 14. pii: S1552-5260(18)30049.
    PubMed     Text format     Abstract available


  112. CONNORS MH, Seeher KM, Crawford J, Ames D, et al
    The stability of neuropsychiatric subsyndromes in Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 13. pii: S1552-5260(18)30048.
    PubMed     Text format     Abstract available


  113. CHIBA-FALEK O, Gottschalk WK, Lutz MW
    The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Alzheimers Dement. 2018 Mar 7. pii: S1552-5260(18)30043.
    PubMed     Text format     Abstract available


    February 2018
  114. TYNKKYNEN J, Chouraki V, van der Lee SJ, Hernesniemi J, et al
    Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.
    Alzheimers Dement. 2018 Feb 28. pii: S1552-5260(18)30020.
    PubMed     Text format     Abstract available


  115. HANSSON O, Seibyl J, Stomrud E, Zetterberg H, et al
    CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Alzheimers Dement. 2018 Feb 27. pii: S1552-5260(18)30029.
    PubMed     Text format     Abstract available


  116. AHMAD S, Bannister C, van der Lee SJ, Vojinovic D, et al
    Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study.
    Alzheimers Dement. 2018 Feb 26. pii: S1552-5260(18)30024.
    PubMed     Text format     Abstract available


  117. COHEN AD, McDade E, Christian B, Price J, et al
    Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
    Alzheimers Dement. 2018 Feb 22. pii: S1552-5260(18)30019.
    PubMed     Text format     Abstract available


  118. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Alzheimers Dement. 2018 Feb 16. pii: S1552-5260(18)30021.
    PubMed     Text format     Abstract available


  119. KNOPMAN DS, Siemers ER, Bain LJ, Hendrix JA, et al
    National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Alzheimers Dement. 2018;14:261-262.
    PubMed     Text format    


    January 2018
  120. MIRON J, Picard C, Nilsson N, Frappier J, et al
    CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Jan 19. pii: S1552-5260(17)33875.
    PubMed     Text format     Abstract available


  121. DI GUARDO G
    Alzheimer's disease, cellular prion protein, and dolphins.
    Alzheimers Dement. 2018 Jan 15. pii: S1552-5260(17)33873.
    PubMed     Text format    


  122. JIA J, Wei C, Chen S, Li F, et al
    The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Alzheimers Dement. 2018 Jan 11. pii: S1552-5260(17)33877.
    PubMed     Text format     Abstract available


  123. HAMPEL H, Toschi N, Baldacci F, Zetterberg H, et al
    Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33872.
    PubMed     Text format     Abstract available


  124. TSE KH, Cheng A, Ma F, Herrup K, et al
    DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33853.
    PubMed     Text format     Abstract available


  125. ACOSTA D, Powell F, Zhao Y, Raj A, et al
    Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.
    Alzheimers Dement. 2018 Jan 4. pii: S1552-5260(17)33857.
    PubMed     Text format     Abstract available


  126. LI K, O'Brien R, Lutz M, Luo S, et al
    A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
    Alzheimers Dement. 2018 Jan 3. pii: S1552-5260(17)33840.
    PubMed     Text format     Abstract available


    December 2017
  127. HALL H, Iulita MF, Gubert P, Aguilar LF, et al
    AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 29. pii: S1552-5260(17)33851.
    PubMed     Text format     Abstract available


  128. CHUNG J, Wang X, Maruyama T, Ma Y, et al
    Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.
    Alzheimers Dement. 2017 Dec 20. pii: S1552-5260(17)33842.
    PubMed     Text format     Abstract available


  129. LEUZY A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, et al
    Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 18. pii: S1552-5260(17)33844.
    PubMed     Text format     Abstract available


  130. BECKER RE, Kapogiannis D, Greig NH
    Does traumatic brain injury hold the key to the Alzheimer's puzzle?
    Alzheimers Dement. 2017 Dec 12. pii: S1552-5260(17)33843.
    PubMed     Text format     Abstract available


  131. PASPALAS CD, Carlyle BC, Leslie S, Preuss TM, et al
    The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.
    Alzheimers Dement. 2017 Dec 11. pii: S1552-5260(17)33841.
    PubMed     Text format     Abstract available


    November 2017
  132. BROOKMEYER R, Abdalla N, Kawas CH, Corrada MM, et al
    Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Alzheimers Dement. 2017 Nov 29. pii: S1552-5260(17)33813.
    PubMed     Text format     Abstract available


  133. STEFANIAK JD, Su L, Mak E, Bahaei NS, et al
    Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Nov 18. pii: S1552-5260(17)33809.
    PubMed     Text format     Abstract available


  134. VIDONI ED, Bothwell RJ, Burns JM, Dwyer JR, et al
    Novel recruitment models will drive Alzheimer's trial success.
    Alzheimers Dement. 2017 Nov 17. pii: S1552-5260(17)33793.
    PubMed     Text format    


    October 2017
  135. MONTAL V, Vilaplana E, Alcolea D, Pegueroles J, et al
    Cortical microstructural changes along the Alzheimer's disease continuum.
    Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33767.
    PubMed     Text format     Abstract available


  136. ALLEN M, Wang X, Burgess JD, Watzlawik J, et al
    Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33766.
    PubMed     Text format     Abstract available


  137. CRANE PK, Foroud T, Montine TJ, Larson EB, et al
    Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33764.
    PubMed     Text format     Abstract available


  138. AN Y, Varma VR, Varma S, Casanova R, et al
    Evidence for brain glucose dysregulation in Alzheimer's disease.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33765.
    PubMed     Text format     Abstract available


  139. HAMPEL H, Mesulam MM, Cuello AC, Khachaturian AS, et al
    Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.
    Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719.
    PubMed     Text format     Abstract available


    September 2017
  140. GUNN-MOORE D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, et al
    Alzheimer's disease in humans and other animals-A consequence of postreproductive life span and longevity rather than aging.
    Alzheimers Dement. 2017 Sep 30. pii: S1552-5260(17)33717.
    PubMed     Text format     Abstract available


  141. CRUCHAGA C, Del-Aguila JL, Saef B, Black K, et al
    Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.
    Alzheimers Dement. 2017 Sep 21. pii: S1552-5260(17)33708.
    PubMed     Text format     Abstract available


  142. XU M, Zhang DF, Luo R, Wu Y, et al
    A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 15. pii: S1552-5260(17)33707.
    PubMed     Text format     Abstract available


  143. GEERTS H, Hofmann-Apitius M, Anastasio TJ
    Knowledge-driven computational modeling in Alzheimer's research: Current state and future trends.
    Alzheimers Dement. 2017 Sep 14. pii: S1552-5260(17)33690.
    PubMed     Text format     Abstract available


  144. LIN PJ, Zhong Y, Fillit HM, Cohen JT, et al
    Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 5. pii: S1552-5260(17)33687.
    PubMed     Text format     Abstract available


    August 2017
  145. KNOPMAN D, Alford E, Tate K, Long M, et al
    Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Alzheimers Dement. 2017;13:940-946.
    PubMed     Text format     Abstract available


  146. WOLF D, Bocchetta M, Preboske GM, Boccardi M, et al
    Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry.
    Alzheimers Dement. 2017;13:893-902.
    PubMed     Text format     Abstract available


  147. GRILL JD, Cox CG, Kremen S, Mendez MF, et al
    Patient and caregiver reactions to clinical amyloid imaging.
    Alzheimers Dement. 2017;13:924-932.
    PubMed     Text format     Abstract available


    July 2017
  148. CRANE A, Brubaker WD, Johansson JU, Trigunaite A, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: 2. Relationship to Abeta immunotherapy.
    Alzheimers Dement. 2017 Jul 26. pii: S1552-5260(17)32898.
    PubMed     Text format     Abstract available


  149. LUTSEY PL, Misialek JR, Mosley TH, Gottesman RF, et al
    Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32522.
    PubMed     Text format     Abstract available


  150. KINNUNEN KM, Cash DM, Poole T, Frost C, et al
    Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32521.
    PubMed     Text format     Abstract available


  151. FRAIN L, Swanson D, Cho K, Gagnon D, et al
    Association of cancer and Alzheimer's disease risk in a national cohort of veterans.
    Alzheimers Dement. 2017 Jul 12. pii: S1552-5260(17)30218.
    PubMed     Text format     Abstract available


  152. BURGGREN AC, Mahmood Z, Harrison TM, Siddarth P, et al
    Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE epsilon4 variant.
    Alzheimers Dement. 2017;13:739-748.
    PubMed     Text format     Abstract available


    June 2017
  153. CRANE PK, Trittschuh E, Mukherjee S, Saykin AJ, et al
    Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.
    Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216.
    PubMed     Text format     Abstract available


  154. DRACHMAN DA, Smith TW, Alkamachi B, Kane K, et al
    Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219.
    PubMed     Text format     Abstract available


  155. CHOURAKI V, Preis SR, Yang Q, Beiser A, et al
    Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Alzheimers Dement. 2017 Jun 8. pii: S1552-5260(17)30200.
    PubMed     Text format     Abstract available


  156. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Text format     Abstract available


  157. PASCOAL TA, Mathotaarachchi S, Shin M, Benedet AL, et al
    Synergistic interaction between amyloid and tau predicts the progression to dementia.
    Alzheimers Dement. 2017;13:644-653.
    PubMed     Text format     Abstract available


  158. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.
    Alzheimers Dement. 2017;13:654-662.
    PubMed     Text format     Abstract available


  159. SCHELLE J, Hasler LM, Gopfert JC, Joos TO, et al
    Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.
    Alzheimers Dement. 2017;13:701-709.
    PubMed     Text format     Abstract available


    May 2017
  160. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Text format     Abstract available


  161. WILLETTE AA, Webb JL, Lutz MW, Bendlin BB, et al
    Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Alzheimers Dement. 2017 May 10. pii: S1552-5260(17)30148.
    PubMed     Text format     Abstract available


  162. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Text format     Abstract available


  163. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Text format     Abstract available


    April 2017
  164. CARMONA-IRAGUI M, Balasa M, Benejam B, Alcolea D, et al
    Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2017 Apr 29. pii: S1552-5260(17)30146.
    PubMed     Text format     Abstract available


  165. CARRILLO MC, Fillit H, Ganguli M, Knopman D, et al
    Letter to the Editor re: Nexus of Cancer & Alzheimer's.
    Alzheimers Dement. 2017 Apr 19. pii: S1552-5260(17)30142.
    PubMed     Text format    


  166. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Text format     Abstract available


    March 2017
  167. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Text format     Abstract available


  168. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Text format     Abstract available


  169. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Text format     Abstract available


  170. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Text format     Abstract available


  171. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Text format     Abstract available


  172. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Text format     Abstract available


  173. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Text format     Abstract available


  174. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Text format     Abstract available


  175. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Text format     Abstract available


  176. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Text format     Abstract available


  177. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.
    PubMed     Text format    


  178. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Text format     Abstract available


  179. SIMONSEN AH, Herukka SK, Andreasen N, Baldeiras I, et al
    Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
    Alzheimers Dement. 2017;13:274-284.
    PubMed     Text format     Abstract available


  180. TON TGN, DeLeire T, May SG, Hou N, et al
    The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
    Alzheimers Dement. 2017;13:217-224.
    PubMed     Text format     Abstract available


    February 2017
  181. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Text format     Abstract available


  182. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Text format     Abstract available


  183. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Text format     Abstract available


  184. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Text format     Abstract available


  185. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed     Text format    


  186. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Text format     Abstract available


  187. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Text format     Abstract available


  188. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Text format     Abstract available


  189. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Text format     Abstract available


  190. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Text format     Abstract available


  191. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Text format     Abstract available


  192. OVERK C, Masliah E
    Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease.
    Alzheimers Dement. 2017;13:183-185.
    PubMed     Text format    


    January 2017
  193. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Text format     Abstract available


  194. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.
    PubMed     Text format    


  195. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Text format     Abstract available


  196. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Text format     Abstract available


  197. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Text format     Abstract available



  198. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Text format     Abstract available


    December 2016
  199. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Text format     Abstract available


  200. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Text format     Abstract available


  201. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Text format     Abstract available


  202. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Text format     Abstract available


    November 2016
  203. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Text format     Abstract available


  204. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Text format     Abstract available


  205. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Text format     Abstract available


  206. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.
    PubMed     Text format    


    October 2016
  207. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Text format     Abstract available


  208. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Text format     Abstract available


  209. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Text format     Abstract available


  210. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Text format     Abstract available


  211. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Text format     Abstract available


  212. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Text format     Abstract available


    September 2016
  213. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Text format     Abstract available


  214. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Text format     Abstract available


  215. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Text format     Abstract available


  216. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Text format     Abstract available


  217. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Text format     Abstract available


  218. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Text format     Abstract available


  219. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Text format     Abstract available


  220. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Text format     Abstract available


    April 2016
  221. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Text format     Abstract available


  222. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Text format     Abstract available


    February 2016
  223. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Text format     Abstract available


  224. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: